GMED vs ISRG
Globus Medical vs Intuitive Surgical — AI-powered side-by-side comparison
GMED
Globus Medical
69
Buy
VS
ISRG
Intuitive Surgical
60
Buy
| Metric | GMED | ISRG |
|---|
| AI Score |
69
|
60
|
| Price |
$83.02
|
$371.73
|
| P/E Ratio |
21.18×
|
42.21×
|
| ROE |
11.8%
|
16.0%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
68.5%
|
66.7%
|
| Debt / Equity |
0.02×
|
0.00×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
46.8
|
40.0
|
| Beta |
0.954
|
1.46
|
| Expected Upside |
+0.2%
|
+18.5%
|
AI Committee View
Current Innellis committee reasoning for GMED versus ISRG.
GMED leads by 9 points.
GMED scores 69/100 (Buy) versus ISRG at 60/100 (Buy).
GMED Committee View
100% agreement
6 analysts
The primary driver is eps growing 50.9% yoy. The main limiting factor is sector concentration is already high (hhi 3068.56). The committee is constructive but not yet at full conviction.
Bull Case
- EPS growing 50.9% YoY — Growth
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical
ISRG Committee View
50% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- ROE of 17.8% shows genuine earnings power backing the valuation — Value
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- P/E of 45.2 is expensive by classic value standards — Value
- Price-to-book of 11.3x prices in significant intangible value — Value
- MACD histogram negative -- bearish momentum — Technical